Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-017304

Director sold 20,000 shares at $57.80 ($1,156,000)

  • Director acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Pellini Michael J Director 2021-03-01 Option exercise +20,000 $6.55 $131,000 20,000 D: show line 1 in the form
Pellini Michael J Director 2021-03-01 Sale −20,000 $57.80 $1,156,000 0 D: show line 2 in the form
Open-market sales · 20,000 sh · avg $57.80 · $1,156,000

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Pellini Michael J Director 2021-03-01 Option exercise · Stock Option (Right to Buy) −20,000 55,000 D: show line 3 in the form
Loading xslF345X03/doc4.xml…